Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.
Research on using drugs in medicine was almost completely stopped and delegalized in 1971, by Convention on Psychotropic Substances. Most of studies carried out before 1971 were methodologically inappropriate according to current research methodologies, yet it was proven that there is some potential...
Saved in:
Main Author: | Agata Tadeja (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Will psilocybin lose its magic in the clinical setting?
by: Caroline Hayes, et al.
Published: (2022) -
Natural products as LSD1 inhibitors for cancer therapy
by: Yuan Fang, et al.
Published: (2021) -
The war on marijuana: The transformation of the war on drugs in the 1990s
by: Mauer Marc, et al.
Published: (2006) -
Pharmacological effects of methylone and MDMA in humans
by: Lourdes Poyatos, et al.
Published: (2023) -
Rediscovering Psilocybin as an Antidepressive Treatment Strategy
by: Rene Zeiss, et al.
Published: (2021)